Clene Inc

NASDAQ:CLNN 4:00:00 PM EDT

0.33

-0.01 (-2.86%)

7:59:53 PM EDT: $0.32 -0.01 (-4.52%)

Market Cap (Intraday)	42.37M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.16 Million
Adjusted EPS	-$0.08

See more estimates

10-Day MA	$0.36
50-Day MA	$0.41
200-Day MA	$0.51

See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121

United States of America

Phone: +1.801.676.9695

Number of Employees: 85

http://www.clene.com

Description

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.